NEIL CHEVALLIER: Open Payments
NPI 1063835577 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 86 payments from 17 companies in 2025. Trend: 2023 $1,475 · 2024 $1,403 · 2025 $1,697
Food & beverage: $1,611Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 11 | $268 |
| Janssen Biotech, Inc. | 17 | $246 |
| ABBVIE INC. | 11 | $219 |
| GENZYME CORPORATION | 8 | $158 |
| UCB, Inc. | 7 | $149 |
| Lilly USA, LLC | 7 | $137 |
| Incyte Corporation | 6 | $118 |
| Regeneron Healthcare Solutions, Inc. | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Organon LLC | 4 | $49 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, Bimzelx, TALTZ, OPZELURA, RINVOQ, SKYRIZI.
Industry payments across LA — which companies pay providers there.
